ArticleFrontiers in pharmacology2021

Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway.

Wanyun Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.